# Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clinical-effectiveness-tolerability-and-cost-effectiveness-of-newer-drugs-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jennifer Wilby,A Kainth,Neil Hawkins,David Epstein,Heather McIntosh,Catriona McDaid,Anne Mason,Su Golder,Susan O’Meara,Mark Sculpher,Michael Drummond,Forbes Ca |
| Citations | 271 |
| DOI | 10.3310/hta9150 |
| Fields | Economics, Econometrics and Finance,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://njl-admin.nihr.ac.uk/document/download/2004965 |
| OpenAlex ID | https://openalex.org/W2111106069 |
| PMID | 15842952 |
| Type | review |
| Year | 2005 |

## Paper authors

- [Neil Hawkins](https://scholariq.org/researchers/neil-hawkins/)
- [Mark Sculpher](https://scholariq.org/researchers/mark-sculpher/)

## Paper journal

- [Health Technology Assessment](https://scholariq.org/journals/health-technology-assessment/)

## Paper primary topic

- [Epilepsy research and treatment](https://scholariq.org/topics/epilepsy-research-and-treatment/)

## Paper topics

- [Epilepsy research and treatment](https://scholariq.org/topics/epilepsy-research-and-treatment/)
- [Pharmacological Effects and Toxicity Studies](https://scholariq.org/topics/pharmacological-effects-and-toxicity-studies/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.